Susan Hasty, Publisher
Table of Contents . . . April 6th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Medical Device Business Week | Other Publications
A.P. Pharma, Inc. - Pharmaceutical firm reports 11% increase in revenues, provides clinical update
AVI BioPharma, Inc. - Biotech firm reports loss of $0.14 per share
Able Laboratories, Inc. - Pharmaceutical firm reports 54.7% increase in gross profits
Adolor Corporation - Biopharmaceutical firm reports loss of $1.12 per share
Aksys, Ltd. - Dialysis product maker reports loss of $0.26 per share
Alantos Pharmaceuticals Holding, Inc. - Biopharmaceutical company raises $20M in private placement
Altachem Pharma, Ltd. - Pharmaceutical firm closes first tranche of private placement
Ambion, Inc. - Alliance with Wyeth continues for development of RNA for vaccine production
Ardana - Pharmaceutical firm announces successful completion of IPO
Aspreva Pharmaceuticals Corporation - Pharmaceutical company announces IPO pricing
BioProgress plc - Finance director named at drug delivery firm
Biota Holdings Limited - Flu drug development agreement signed
Biovail Corporation - Pharmaceutical firm provides 2005 guidance, strategy update
Business & Finance - Pharma company reports year-end operating results, product candidates progress
Caraco Pharmaceutical Laboratories - Pharmaceutical firm reports loss of $0.01 per share
Spectrum - New York-based magazine dedicated to autism goes national
A.C.T. Holdings - First derivation of human embryonic stem cells without exposure to cell feeders
AG Reproductive Immunology, Berlin - Heme oxygenase could be therapeutic target in immunological pregnancy problems
AGOWA GmbH - Companies form strategic co-operation for identification of bacteria and fungi
Aarhus University Hospital - Angiogenic cytokines predict multiple myeloma progression
Accelrys - Science informatics company launches independent software vendor partner program
Adventrx Pharmaceuticals, Inc. - Primary endpoint met in CoFactor phase II metastatic colorectal cancer trial
Ajou University, Suwon - Case study of myxoid clear cell sarcoma reported
Alcon Laboratories Inc. - Wettability of treated and untreated pHEMA-MAA soft lenses determined
Alcon, Inc. - Eye care company reports clinical study data on macular degeneration
Alimera Sciences, Inc. - Ophthalmic pharmaceutical firm names Phil Tracy chairman of the board
Allon Therapeutics, Inc. - Glaucoma compounds show potential to treat eye disease
AmCyte, Inc. - Islet transplant completed in a patient with type 1 diabetes
American College of Physician Executives - Survey showing unethical business practices in U.S. healthcare alarms physicians
Aphton Corporation - Biopharmaceutical firm names Susan Watson as chief scientific officer
Applied Biosystems - Deal signed to develop metabolomics methods, instruments
Arcturus Bioscience, Inc. - Biotech company appoints CEO
AstraZeneca - EPO rules Symbicort combination patent still valid
AstraZeneca - Therapy for dementia in elderly, risk of cerebrovascular adverse event studied
AstraZeneca R&D - Activation of PPARalpha heightens hepatic MTP activity
Australian Research Council - Australian group makes inroads to male infertility
Autonomous University of Madrid - Differences between sexes in HSV-1 infection and disease studied
Avanir Pharmaceuticals - Rights to Neurodex technology acquired
BC Cancer Agency - British Columbia recruits top cancer researcher from U.K.
BD Technologies - Findings describe new data in influenza vaccines research
Basilea Pharmaceutica AG - Antibiotic for acne, rosacea moves into preclinical trials
Baylor College of Medicine, Houston - Low molecular weight cyclin E isoforms augment melanoma metastasis
Bellevue Hospital, New York - Two broad groups of uterine fibroids defined by gene expression
Bichat Claude Bernard Hospital, Paris - New data illuminates research in hypertension
Bio-Imaging Technologies, Inc - Contract services company customizes products for training
Bio-Reference Laboratories, Inc. - Clinical lab company records 27% increase in first quarter net revenues
BioDelivery Sciences International, Inc. - Phase III trials of Bema fentanyl to be initiated
BioGenex Laboratories, Inc. - Medical device maker appoints Jeffrey S. Ross as medical director
BioSource International, Inc. - Life sciences company reports 9% increase in sales
BioTech Holdings Ltd. - Diabetes drug TV, print advertising gets approval of Mexico's medical regulator
Biogen Idec - Update provided on Tysabri for multiple sclerosis
Biosyntech - Agreement signed for CRO for clinical trials
Blue Cross Blue Shield of Missouri - Stuart Campbell named president and CEO Missouri, Wisconsin health plan company
Brandeis University, Waltham - Salmonella typhimurium flagellar hook studied, atomic structure reported
Brigham & Women's Hospital, Boston - Reports add new data to angiology research
Brigham Young University, Utah - Workplace health promotion programs show 16:1 return on investment
Brown University - G-protein studied, role of subunits in fertilization Ca2+ release revealed
Business & Finance - ICL Industrial Products announces price increases for clear brine fluids
Business Update - Fairmount Park Commission approves Fox Chase Cancer Center expansion plan
Cancer Center & Research Center - New research targets men to study virus that causes cancer in women
Cantel Medical Corp. - Infection control device maker reports 51% increase in revenue
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.